1. <td id="ooa1h"><noscript id="ooa1h"><ol id="ooa1h"></ol></noscript></td>
        <td id="ooa1h"><option id="ooa1h"></option></td>
        1. <td id="ooa1h"><strike id="ooa1h"></strike></td>
        2. 研發條件1.jpg

          BCHT, always attaching great importance to R&D and optimize the allocation of resources continuously, is fully equipped for biological vaccine research and pilot production with laboratories and pilot plants covering totally nearly 9,700 ㎡ and more than 1,180 sets of various advanced experimental equipments or instruments, and can meet the demands of simultaneous R&D on the virus culture scale-up technology platform, final product and adjuvant technology platform, genetic engineering technology platform, and bacterial vaccine technology platform.